Edition:
India

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

129.22USD
17 Nov 2017
Change (% chg)

$0.61 (+0.47%)
Prev Close
$128.61
Open
$128.19
Day's High
$129.62
Day's Low
$127.69
Volume
58,614
Avg. Vol
63,283
52-wk High
$132.48
52-wk Low
$95.68

Latest Key Developments (Source: Significant Developments)

Bio-Techne releases Q1 adjusted earnings per share $0.90
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Bio-Techne Corp :Bio-Techne releases first quarter fiscal 2018 results.Q1 adjusted earnings per share $0.90.Q1 GAAP earnings per share $0.42.Q1 sales $144.6 million versus I/B/E/S view $142.9 million.Q1 earnings per share view $0.88 -- Thomson Reuters I/B/E/S.  Full Article

Bio-Techne posts Q4 adjusted EPS of $0.92
Wednesday, 17 Aug 2016 

Bio-techne Corp : Q4 adjusted earnings per share $0.92 . Q4 earnings per share view $0.96 -- Thomson Reuters I/B/E/S . Techne releases fourth quarter fiscal 2016 results . Q4 gaap earnings per share $0.69 . Q4 sales $134.8 million versus i/b/e/s view $129.2 million .Techne - in q4, incurred transactional foreign exchange losses due to fall of british pound and european commercial operations being based in uk.  Full Article

Bio-Techne signs credit agreement
Tuesday, 2 Aug 2016 

Bio-Techne Corp : On July 28, 2016, Bio-Techne Corp entered into a credit agreement - sec filing . Credit agreement matures on July 28, 2021 . Credit agreement provides for revolving credit facility of $400 million, which can be increased by additional $200 million subject to conditions .At closing on July 28, co drew $343.5 million on credit agreement in relation to closing of merger and for payment of outstanding debt.  Full Article

Bio-Techne to acquire Advanced Cell Diagnostics for $250 mln
Thursday, 7 Jul 2016 

Bio-techne Corp : Bio-Techne announces agreement to acquire advanced cell diagnostics . Techne -to acquire advanced cell diagnostics for $250 million in cash plus contingent consideration of $75 million due upon achievement of milestones . Techne corp - acquisition is expected to be accretive after 2017 . Techne corp - transaction will be financed through a combination of cash on hand and a revolving line of credit facility .Techne corp - acquisition is expected to be slightly dilutive to bio-techne's adjusted earnings per share for its fiscal year 2017.  Full Article

Bio-Techne to buy Space Import-Export Srl of Milan, Italy
Saturday, 2 Jul 2016 

Bio-Techne Corp: Techne Corp says to acquire Space Import-Export Srl of Milan, Italy .Bio-Techne- Space's Luca Cicchetti, will remain with Bio-Techne as managing director and lead Co's southern European commercial operations.  Full Article

Bio-Techne Corp declares dividend
Tuesday, 3 May 2016 

Bio-Techne Corp:Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2016.Quarterly dividend will be payable May 27, 2016 to all common shareholders of record on May 13, 2016.  Full Article

Bio-Techne Corp declares dividend
Tuesday, 2 Feb 2016 

Bio-Techne Corp:Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended December 31, 2015.Quarterly dividend will be payable February 26, 2016 to all common shareholders of record on February 12, 2016.  Full Article

BRIEF-Women In Bio announces that Alpna Seth joins Bio-Techne's board

* Women In Bio announces that Alpna Seth joins Bio-Techne's board of directors Source text for Eikon: